Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)

J. P. Dyke, D. Sondhi, H. U. Voss, K. Yohay, C. Hollmann, D. Mancenido, S. M. Kaminsky, L. A. Heier, K. D. Rudser, B. Kosofsky, B. J. Casey, Ronald Crystal, D. Ballon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.

Original languageEnglish
Pages (from-to)1160-1169
Number of pages10
JournalAmerican Journal of Neuroradiology
Volume37
Issue number6
DOIs
Publication statusPublished - 1 Jun 2016
Externally publishedYes

Fingerprint

Neuronal Ceroid-Lipofuscinoses
Disease Progression
Brain
Lysosomal Storage Diseases
Software
Mutation
Population
Genes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease). / Dyke, J. P.; Sondhi, D.; Voss, H. U.; Yohay, K.; Hollmann, C.; Mancenido, D.; Kaminsky, S. M.; Heier, L. A.; Rudser, K. D.; Kosofsky, B.; Casey, B. J.; Crystal, Ronald; Ballon, D.

In: American Journal of Neuroradiology, Vol. 37, No. 6, 01.06.2016, p. 1160-1169.

Research output: Contribution to journalArticle

Dyke, JP, Sondhi, D, Voss, HU, Yohay, K, Hollmann, C, Mancenido, D, Kaminsky, SM, Heier, LA, Rudser, KD, Kosofsky, B, Casey, BJ, Crystal, R & Ballon, D 2016, 'Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)', American Journal of Neuroradiology, vol. 37, no. 6, pp. 1160-1169. https://doi.org/10.3174/ajnr.A4669
Dyke, J. P. ; Sondhi, D. ; Voss, H. U. ; Yohay, K. ; Hollmann, C. ; Mancenido, D. ; Kaminsky, S. M. ; Heier, L. A. ; Rudser, K. D. ; Kosofsky, B. ; Casey, B. J. ; Crystal, Ronald ; Ballon, D. / Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease). In: American Journal of Neuroradiology. 2016 ; Vol. 37, No. 6. pp. 1160-1169.
@article{b62144b611e14a24a76590424aa5f7be,
title = "Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)",
abstract = "BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.",
author = "Dyke, {J. P.} and D. Sondhi and Voss, {H. U.} and K. Yohay and C. Hollmann and D. Mancenido and Kaminsky, {S. M.} and Heier, {L. A.} and Rudser, {K. D.} and B. Kosofsky and Casey, {B. J.} and Ronald Crystal and D. Ballon",
year = "2016",
month = "6",
day = "1",
doi = "10.3174/ajnr.A4669",
language = "English",
volume = "37",
pages = "1160--1169",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 Disease)

AU - Dyke, J. P.

AU - Sondhi, D.

AU - Voss, H. U.

AU - Yohay, K.

AU - Hollmann, C.

AU - Mancenido, D.

AU - Kaminsky, S. M.

AU - Heier, L. A.

AU - Rudser, K. D.

AU - Kosofsky, B.

AU - Casey, B. J.

AU - Crystal, Ronald

AU - Ballon, D.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.

AB - BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.

UR - http://www.scopus.com/inward/record.url?scp=84974593890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974593890&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A4669

DO - 10.3174/ajnr.A4669

M3 - Article

VL - 37

SP - 1160

EP - 1169

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -